Linkedin
Sign in
Join
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Type here...
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
Twitter
Subscribe
Subscribe
Sunday, February 1, 2026
24.4
C
Bengaluru
Home
About
Editor’s Corner
Contribute
Contact Us
My account
Get into your account.
Login
Register
type here...
Search
Facebook
Linkedin
Twitter
Youtube
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies
0
April 14, 2025 India’s pharmaceutical industry, a global powerhouse, sends...
Trump Tariff and the Trade Turbulence – A Salil Kallianpur Blog
0
Impact of Trump’s 100% tariff on imported patented/innovative drugs...
India’s Medical Devices Market: Strategic Implications and Key Investors
0
KKR's Investments in India's Medical Devices Market: Strategic Implications...
India’s Patent Revocations: Strengthening Access and Challenging Evergreening
0
The Indian Patent Office’s recent decision to revoke Novartis’...
What Can Pharma Learn about Customer Experience from Other Industries?
0
In today's competitive retail world, lower pricing and creative...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Marketing
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Policies/Sales
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Strategy
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Subscribe
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Hot topics
Cipla–Pfizer Deal: How “Ordinary” Brands Are Fueling an Extraordinary Power Shift in Indian Pharma
0
What’s really happening in the Cipla–Pfizer tie‑up At first glance,...
Nimesulide – Nice or Not Nise?
0
Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...
3 Rules of the Digital World for Pharma Brand Managers
0
The first time I heard the term ‘digital economy’...
What about Indian Pharma?
0
Articles by K. Hariram, Vivek Hattangadi, Soham Wagh, Dr. Rajshri Jobanputra, and Rashesh Patel
Healthcare Marketing in the Covid-19 Era
0
How should healthcare business leaders (pharma, devices, diagnostics, disposables...
Facebook
Linkedin
Twitter
Youtube
Healthcare Trends
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Marketing
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Policies/Sales
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Strategy
IQVIA vs. PharmaTrac: Indian Pharma Market Data
0
Here is an analytical blog comparing the IQVIA MFR...
Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead
0
The latest PharmaTrac report for December 2025 offers a...
Orphan Drugs and Indian Pharma: Moving from Volume to Value?
0
Zydus’ ZYCUBO May Be the Proof Point the Industry...
Arjun Arunachalam: The Man Who Deleted Helium
0
For more than fifty years, the MRI industry treated...
Who Is Monitoring Quality in India’s Small Drug Units?
0
The Telangana Drugs Control Administration’s stop-use notice on a...
Subscribe
Piyush Agarwal
Piyush Agarwal is AVP – Business Strategy at Intas Pharmaceuticals Ltd. Email: piyush3110@gmail.com
Five Disruptive Forces Shaking Up Indian Pharma
Thought Leadership
Piyush Agarwal
-
July 7, 2016
A curtain raiser on disruptions that will permanently alter the pharma marketing landscape in the near future.